rediff.com
e.g. Tata motors, Reliance MF, 500570
BSE

Novartis India Ltd.

500672 NOVARTIND Group (B)

02 Dec,15:48
1071.25
-19.05 (-1.75%)
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

Add to Watchlist
 
Day
Wk
Mn
6Mn
Yr
Volume Prev close Day's H/L (Rs.) 52wk H/L (Rs.) Mkt Cap (Rs. Cr)

Novartis India Ltd.

BUYSELL

3,483 1,090.30 1,100.00 - 1,055.00 1,248.00 - 692.30 2,645.99

News for Novartis India Ltd.

Natco Pharma...
Natco Pharma Files Generic Cancer Drug Application with USFDA - Business News
Natco Pharma has submitted an ANDA to the USFDA for a generic version of Novartis' Tabrecta, a cancer drug. The company expects to be eligible for 180 days of marketing exclusivity.
Aug 29, 2024 17:10
Pharma Budget...
Pharma Budget Wish List: Tax Benefits, IP Rights
Pharma industry bodies call for tax incentives, stronger IP regime and R&D support in the upcoming Union Budget to boost domestic growth.
Jul 07, 2024 11:15
Alembic Pharma...
Alembic Pharma Gets USFDA Nod for Heart Failure Drug
Alembic Pharmaceuticals receives USFDA approval to market a generic medication for heart failure, a therapeutically equivalent version of Novartis's Entresto tablets.
May 30, 2024 16:20
India's Growing...
India's Growing Appeal for Clinical Trials: Pharma Leaders Speak
Pharma industry leaders highlight India's rising attractiveness for clinical trials, citing recent reforms and a robust healthcare infrastructure. Learn about the factors driving this trend.
Apr 27, 2024 19:35
Novartis India Strategic Review: Impact on Listed Business
Novartis AG announces a strategic review of Novartis India Ltd, its listed subsidiary, assessing its 70.68% shareholding. The review does not impact Novartis Healthcare Pvt Ltd.
Feb 16, 2024 22:31

More News for Novartis India Ltd. »

(Rs. Crore)

Financial Results of Novartis India Ltd.

Mar ' 24Mar ' 23Mar ' 22Mar ' 21Mar ' 20
Sales335.07378.74399.87381.35438.25
Operating profit65.2665.0827.1126.7912.03
Interest1.491.754.837.686.39
Gross profit125.45121.4455.4752.2041.78
EPS (Rs)34.5241.88-1.518.474.08

See more in Research Center »

News for Pharmaceuticals and health care

FSSAI...
FSSAI Reclassifies Packaged Water as High-Risk, Mandates Stricter Checks
The FSSAI has reclassified packaged drinking water as a high-risk food category, requiring stricter regulations, annual inspections, and third-party audits. This move aims to enhance consumer...
Dec 02, 2024 22:59
Sebi Bans 'Baap...
Sebi Bans 'Baap of Chart' & 6 Others for Unregistered Investment Advice
Sebi has banned 'Baap of Chart' and six others for one year for providing unregistered investment advice. The regulator also directed them to refund Rs 17.2 crore to investors.
Dec 02, 2024 22:37
RBI Urges Banks...
RBI Urges Banks to Reduce Inoperative Accounts
The RBI has directed banks to reduce inoperative accounts urgently, citing concerns about rising unclaimed deposits. Banks must report their progress quarterly.
Dec 02, 2024 22:14
APFD, APFDC & ISB...
APFD, APFDC & ISB Partner to Revitalize Forest Economies
Andhra Pradesh government and ISB collaborate to empower women and revitalize forest economies through sustainable practices and community development.
Dec 02, 2024 21:55
Kerala Attracts...
Kerala Attracts Rs 44,000 Crore Investment: Minister
Kerala has attracted Rs 44,000 crore investment from domestic entrepreneurs in the last three and a half years, according to Industries Minister P Rajeeve. The state is on track for industrial...
Dec 02, 2024 21:31

More News »

Top News

FSSAI...
FSSAI Reclassifies Packaged Water as High-Risk, Mandates Stricter Checks
The FSSAI has reclassified packaged drinking water as a high-risk food category, requiring stricter regulations, annual inspections, and third-party audits. This move aims to enhance consumer...
Dec 02, 2024 22:59
Sebi Bans 'Baap...
Sebi Bans 'Baap of Chart' & 6 Others for Unregistered Investment Advice
Sebi has banned 'Baap of Chart' and six others for one year for providing unregistered investment advice. The regulator also directed them to refund Rs 17.2 crore to investors.
Dec 02, 2024 22:37
GST Compensation...
GST Compensation Cess: GoM Seeks Extension for Report
The GoM on GST compensation cess has requested a 6-month extension to submit its report to the GST Council. The GoM is examining legal issues related to the cess and its future course.
Dec 02, 2024 22:32
Godrej Properties...
Godrej Properties Raises Rs 6,000 Crore via QIP
Godrej Properties successfully raised Rs 6,000 crore through a qualified institutional placement (QIP) to fuel its expansion amidst strong demand in the real estate sector.
Dec 02, 2024 22:20
GST Hike on...
GST Hike on Cigarettes, Tobacco, Beverages: 35% Proposed
India's GST Council may hike taxes on sin goods like cigarettes, tobacco, and aerated beverages to 35% on Dec 21. The decision comes after a GoM recommendation for rate rationalization.
Dec 02, 2024 22:15

More Top News »

Report Card

PE Ratios
31.03
EPS (Rs.)
34.52
Sales (Rs. Cr)
87.10
Face Value (Rs.)
5
Net Profit Margin (%)
25.42
Last Bonus
1:2
Last Dividend(%)
500
Return on Average Equity
11.43

Compare 'Novartis India Ltd.' with other stocks

  • Sun Pharmaceutical Industries Ltd.
  • 1,781.65
  • Compare
  • Divi's Laboratories Ltd.
  • 6,171.05
  • Compare
  • Torrent Pharmaceuticals Ltd.
  • 3,326.90
  • Compare
  • Dr. Reddy's Laboratories Ltd.
  • 1,202.35
  • Compare
  • Apollo Hospitals Enterprise Ltd.
  • 6,829.80
  • Compare
  • Zydus Lifesciences Ltd.
  • 966.15
  • Compare
  • Max Healthcare Institute Ltd.
  • 979.30
  • Compare
  • Aurobindo Pharma Ltd.
  • 1,262.40
  • Compare

Most Active

  • Change (Rs.)
  •  

Novartis India Ltd. performance snapshot

If you had invested Rs.  in Novartis India Ltd.,     ago

You would have  Rs. 0.00 

Add to Portfolio

Peers

  • LTP
  • Change (Rs.)
  • Change %
  • Mkt Cap (Rs. Cr)
  • Volume
Close
Add Novartis India Ltd. to your Portfolio
 
 
BSE NSE  
 
Close
Add Novartis India Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close